Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease

Inflammatory Bowel Disease: A Canadian Burden of Illness Review

(2016) Angela Rocchi et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?

(2014) D. Salat-Foix et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohnʼs Disease, and Ulcerative Colitis Patients

(2013) Scott Plevy et al.   INFLAMMATORY BOWEL DISEASES

Five-Year Mortality in Colorectal Cancer Patients with Ulcerative Colitis or Crohnʼs Disease

(2013) Anne G. Ording et al.   INFLAMMATORY BOWEL DISEASES

The burden of inflammatory bowel disease in Europe

(2013) Johan Burisch et al.   Journal of Crohns & Colitis

Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice

(2012) Yasunari Asano et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model

(2012) Mario Colucci et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Colonic inflammation in Parkinson's disease

(2012) David Devos et al.   NEUROBIOLOGY OF DISEASE

Monoclonal antibodies: magic bullets with a hefty price tag

(2012) A. F. Shaughnessy   BMJ-British Medical Journal

Early endothelial damage and increased colonic vascular permeability in the development of experimental ulcerative colitis in rats and mice

(2011) Ganna Tolstanova et al.   LABORATORY INVESTIGATION

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

(2011) J.-M. Beaulieu et al.   PHARMACOLOGICAL REVIEWS

Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease

(2011) Christopher B. Forsyth et al.   PLoS One

Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells

(2011) D. Chakroborty et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

New molecular mechanisms of the unexpectedly complex role of VEGF in ulcerative colitis

(2010) Ganna Tolstanova et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in endoglin heterozygous mice

(2010) Mirjana Jerkic et al.   INFLAMMATORY BOWEL DISEASES

Novel Highly Effective Medical Treatment of Severe Treatment Refractory Crohnʼs Disease Using Sympathomimetic Amines: Case Report

(2010) Jerome H. Check et al.   INFLAMMATORY BOWEL DISEASES

VEGF164 isoform specific regulation of T-cell-dependent experimental colitis in mice

(2010) John H. Chidlow et al.   INFLAMMATORY BOWEL DISEASES

Feasibility of anti-VEGF agent bevacizumab in patients with Crohnʼs disease

(2010) Romain Coriat et al.   INFLAMMATORY BOWEL DISEASES

Case report showing that a woman with ulcerative colitis refractory to standard therapy responded well to the sympathomimetic amine dextroamphetamine sulfate

(2010) Jerome H. Check et al.   INFLAMMATORY BOWEL DISEASES

Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2

(2009) S. Sinha et al.   JOURNAL OF CELL SCIENCE

Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenib

(2008) Y. Loriot et al.   ANNALS OF ONCOLOGY

Dopamine Increases the Efficacy of Anticancer Drugs in Breast and Colon Cancer Preclinical Models

(2008) C. Sarkar et al.   CLINICAL CANCER RESEARCH

VEGF-A Links Angiogenesis and Inflammation in Inflammatory Bowel Disease Pathogenesis

(2008) Franco Scaldaferri et al.   GASTROENTEROLOGY

Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGF

(2008) G. Tolstanova et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease

(2008) Y.-M. Tian et al.   NEUROSCIENCE